147 related articles for article (PubMed ID: 26808725)
1. c-myc Gene Copy Number Variation in Cervical Exfoliated Cells Detected on Fluorescence in situ Hybridization for Cervical Cancer Screening.
Zhao WH; Hao M; Cheng XT; Yang X; Wang ZL; Cheng KY; Liu FL; Bai YX
Gynecol Obstet Invest; 2016; 81(5):416-23. PubMed ID: 26808725
[TBL] [Abstract][Full Text] [Related]
2. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
3. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
[TBL] [Abstract][Full Text] [Related]
5. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
Li Y; Zeng WJ; Ye F; Wang XY; Lü WG; Ma D; Wei LH; Xie X
Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
[TBL] [Abstract][Full Text] [Related]
6. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
[TBL] [Abstract][Full Text] [Related]
7. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
8. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
[TBL] [Abstract][Full Text] [Related]
9. FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women.
Yang F; Cui Z; Liao Y; Tian R; Fan W; Jin Z; Hu Z; Yao S
Cancer Biomark; 2020; 27(3):303-312. PubMed ID: 31771040
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of TP63 and MYC as biomarkers for transition of cervical intraepithelial neoplasia to cervical cancer.
Zhu D; Jiang XH; Jiang YH; Ding WC; Zhang CL; Shen H; Wang XL; Ma D; Hu Z; Wang H
Int J Gynecol Cancer; 2014 May; 24(4):643-8. PubMed ID: 24662128
[TBL] [Abstract][Full Text] [Related]
11. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
[TBL] [Abstract][Full Text] [Related]
12. Detection of hTERC and c-MYC genes in cervical epithelial exfoliated cells for cervical cancer screening.
Li T; Tang L; Bian D; Jia Y; Huang X; Zhang X
Int J Mol Med; 2014 May; 33(5):1289-97. PubMed ID: 24626956
[TBL] [Abstract][Full Text] [Related]
13. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
[TBL] [Abstract][Full Text] [Related]
14. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
Fan Y; Shen Z
Pathol Res Pract; 2018 May; 214(5):767-775. PubMed ID: 29655523
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions.
Zheng X; Liang P; Zheng Y; Yi P; Liu Q; Han J; Huang Y; Zhou Y; Guo J; Li L
Int J Gynecol Cancer; 2013 Jun; 23(5):785-90. PubMed ID: 23669440
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
[TBL] [Abstract][Full Text] [Related]
17. [Detection of human telomerase RNA component gene by fluorescent in situ hybridization for screening of cervical lesions].
Gao L; Zhu Y; Liu SP; Gao Y; Zhu MH
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):104-7. PubMed ID: 21426806
[TBL] [Abstract][Full Text] [Related]
18. Clinical Role of the Detection of Human Telomerase RNA Component Gene Amplification by Fluorescence in situ Hybridization on Liquid-Based Cervical Samples: Comparison with Human Papillomavirus-DNA Testing and Histopathology.
Zappacosta R; Ianieri MM; Buca D; Repetti E; Ricciardulli A; Liberati M
Acta Cytol; 2015; 59(4):345-54. PubMed ID: 26343271
[TBL] [Abstract][Full Text] [Related]
19. The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.
Yin G; Li J; Zhu T; Zhao X
World J Surg Oncol; 2012 Aug; 10():168. PubMed ID: 22909227
[TBL] [Abstract][Full Text] [Related]
20. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction.
Aoyama C; Peters J; Senadheera S; Liu P; Shimada H
Diagn Mol Pathol; 1998 Dec; 7(6):324-30. PubMed ID: 10207671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
